EVolution Therapeutics is pleased to welcome PhD student Sasha Kieran for a three-month work experience placement as part of her MIBTP programme. During her time...
EVolution Therapeutics was delighted to have been invited to exhibit at Venturefest 2024. Joining an array of innovative start-ups, Dr James Gavin and Alice...
Aston University has issued a press release highlighting the work of Evolution Therapeutics and our mission to leverage the pro-resolving properties of...
Exciting news from Evolution Therapeutics as we welcome Alice Wigington, who has joined the team as a Research Scientist. Alice is a first-class graduate of Aston...
Evolution Therapeutics has been recognised by the Biotechnology and Biosciences Research Council (BBSRC) in their 2023 impact showcase. This showcase serves as a...
EVolution Therapeutics is thrilled to announce its selection to join the first cohort of SPARK The Midlands, the inaugural UK branch of the globally recognised...
CEO of EVolution therapeutics, Dr James Gavin, was invited to present at the first-ever Midlands EV Network event. Here he shared his experience of co-founding...
EVolution Therapeutics has achieved another milestone by securing additional grant funding of £238,000, to work in collaboration with world leading biomaterials...
We are delighted to announce that EVolution Therapeutics has secured a £284,000 Innovate UK grant to develop an advanced wound care therapeutic for the treatment...